Results 131 to 140 of about 30,704 (265)

Cyclophosphamide is associated with long‐term treatment‐free remission in patients with pemphigus

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objective Pemphigus treatment has seen significant advancements, yet long‐term remission remains a challenge. Comparative data on the long‐term effectiveness of available therapies are limited. We compared 10‐year relapse rates in pemphigus patients treated with azathioprine or cyclophosphamide plus high‐dose IV corticosteroids ...
Bettina Santler   +5 more
wiley   +1 more source

Effect and length of doxycycline administration in elderly patients with bullous pemphigoid

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease and primarily affects the elderly. Systemic corticosteroids and immunosuppressive drugs are the standard treatment, but side effects often restrict their use. Doxycycline has been proposed as an alternative, but there is limited long‐term, real‐world data on its
Alena Merkel‐Ropele   +2 more
wiley   +1 more source

Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report. [PDF]

open access: yesCureus
Izadian Bidgoli A   +5 more
europepmc   +1 more source

Episodes of Flushing and Blistering

open access: yesActas Dermo-Sifiliográficas (English Edition), 2010
L, Fuertes, C, Zarco, F, Vanaclocha
openaire   +3 more sources

Home - About - Disclaimer - Privacy